Analysis of ADR reports of cetuximab based on the FDA adverse event reporting system database

Analysis of ADR reports of cetuximab based on the FDA adverse event reporting system database

Abstract This study aims to monitor and identify adverse events (AEs) associated with cetuximab, a drug used to treat various late-stage (metastatic) tumors, to improve patient safety and guide drug use. This study retrospectively analyzed the cases reported in the FDA adverse event reporting system...

Full description

Saved in:
Bibliographic Details
Main Authors: Shuai Zhao, Yan Wang, Xiaoli Deng, Xi Chen, Zhaoyi Lu
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
Cetuximab
Head and neck cancer
Adverse events (AEs)
Adverse drug reactions (ADRs)
Preferred terms (PTs)
System organ class (SOC)
Online Access:https://doi.org/10.1038/s41598-025-88838-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-88838-z

Similar Items